SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 93 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2014. The put-call ratio across all filers is 1.91 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $35,000 | -58.8% | 15,766 | -63.8% | 0.00% | -66.7% |
Q1 2015 | $85,000 | -49.1% | 43,591 | -30.9% | 0.00% | -50.0% |
Q4 2014 | $167,000 | -30.7% | 63,123 | -21.0% | 0.01% | -14.3% |
Q3 2014 | $241,000 | -31.3% | 79,927 | -7.0% | 0.01% | -22.2% |
Q2 2014 | $351,000 | +663.0% | 85,937 | +703.0% | 0.01% | +800.0% |
Q1 2014 | $46,000 | -47.7% | 10,702 | -36.3% | 0.00% | -66.7% |
Q4 2013 | $88,000 | +31.3% | 16,802 | +58.5% | 0.00% | +50.0% |
Q3 2013 | $67,000 | – | 10,601 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 37,069,140 | $64,500,000 | 87.00% |
ARMISTICE CAPITAL, LLC | 2,000,000 | $3,480,000 | 1.19% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 432,259 | $752,000 | 0.28% |
Geller Advisors LLC | 187,323 | $326,000 | 0.21% |
CAXTON CORP | 57,000 | $99,000 | 0.13% |
Verity Asset Management, Inc. | 64,476 | $112,000 | 0.11% |
TFS CAPITAL LLC | 367,364 | $639,000 | 0.06% |
Cutler Capital Management, LLC | 72,500 | $126,000 | 0.06% |
LUCAS CAPITAL MANAGEMENT | 21,100 | $37,000 | 0.02% |
Nine Chapters Capital Management LLC | 129,700 | $226,000 | 0.02% |